HIV

Opioids have caused more than 70% of health events among patients with drug use disorder around the world.

Patentiflorin A better inhibited viral replication than azidothymidine, which could lead to an HIV cure.

Increasingly, individuals with HIV also have comorbid conditions, such as cardiovascular disease, hypertension, and diabetes.

The once-daily drug contains bictegravir and emtricitabine/tenofovir to treat adults with HIV-1.

Competition in HIV drug development affecting stock market.

Inhibiting particle release and infectivity could lead to a cure for HIV-1.

The journal AIDS Care has published a systematic review that looks at the opportunity to provide coordinated care for HIV and non-communicable conditions.

Top news of the day from across the health care landscape.

Merck will present late-breaker abstracts at upcoming IAS 2017 conference.

The Biologics License Application for ibalizumab is under review for the treatment of multidrug resistant HIV-1.

Messaging based on patient medical records allow for more personalized care in HIV and other conditions.

Antibiotic resistance is making gonorrhea increasingly harder to treat, the World Health Organization (WHO) warned in a recently published report.

Walgreens today announced that beginning July 13, providers at Walgreens Healthcare Clinic locations in 17 new markets will be able to prescribe PrEP, a medication protocol for people who don’t have HIV to help proactively protect against HIV infection.

Top articles of the week from Specialty Pharmacy Times.

Researchers focus on generating a robust HIV-neutralizing antibody response.

Mathematical model brings scientists a step closer to developing total viral suppression strategies among patients with HIV.

Can a 1-Hour Intervention Help?

HPV testing results in faster detection and treatment of cervical precancer.

Urinary cytomegalovirus shedding is a significant risk factor for CMV and HIV transmission.

New diagnoses and prevalence of HIV is illustrated by demographics, location, and social determinants of health.

HIV disproportionately affects blacks and Latinos, who are less likely to receive ongoing care.

Top articles of the week from Specialty Pharmacy Times.

Part of the FDA's actions focuses on expediting review of generic applications.

More than 1.1 million Americans are HIV-positive, yet 15% are unaware of their status.

Finding ways to triage patients and identify those with the greatest need is important.